# Aarti K. Bhatia, MD, MPH – FDA 483, Aug 7, 2026

Source: https://www.keypedia.com/records/483/aarti-k-bhatia-md-mph/801078b2-8fa6-426c-a359-b9ac0421e523

> FDA 483 for Aarti K. Bhatia, MD, MPH on August 07, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Aarti K. Bhatia, MD, MPH
- Inspection Date: 2026-08-07
- Product Type: drugs
- Office Name: New England District Office
- Summary: An FDA inspection of Aarti K. Bhatia, MD, MPH, a clinical investigator in New Haven, CT, revealed a significant deficiency related to informed consent. The firm failed to obtain legally effective informed consent or reconsent from multiple subjects for updated ICF versions as required by the IRB. This indicates a serious lapse in protecting human subjects in clinical trials.

## Related Officers

- [investigator](https://www.keypedia.com/people/jose-a-torres/0c491014-1dd0-4024-99b2-203b830b9c2b)

Company: https://www.keypedia.com/companies/aarti-k-bhatia-md-mph/05d20c93-3dd3-47b2-84fd-846afcfcf52a

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144